Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals
Authors
Keywords
-
Journal
Biomedicines
Volume 9, Issue 1, Pages 79
Publisher
MDPI AG
Online
2021-01-16
DOI
10.3390/biomedicines9010079
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity
- (2020) Mariusz L. Hartman et al. Cells
- Targeted Therapy in Melanoma and Mechanisms of Resistance
- (2020) Anna M. Czarnecka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activating KRAS, NRAS, and BRAF mutants enhance proteasome capacity and reduce endoplasmic reticulum stress in multiple myeloma
- (2020) Fazal Shirazi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Current State of Target Treatment in BRAF Mutated Melanoma
- (2020) Enrica Teresa Tanda et al. Frontiers in Molecular Biosciences
- Malignant Melanoma: Autoimmunity and Supracellular Messaging as New Therapeutic Approaches
- (2019) Ion G. Motofei CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Metabolic flexibility in melanoma: A potential therapeutic target
- (2019) Maria Rosaria Ruocco et al. SEMINARS IN CANCER BIOLOGY
- Dual effects of an anti-CD147 antibody for Esophageal cancer therapy
- (2019) Miao Wang et al. CANCER BIOLOGY & THERAPY
- Theophylline induces differentiation and modulates cytoskeleton dynamics and cytokines secretion in human melanoma-initiating cells
- (2019) Martina Cordella et al. LIFE SCIENCES
- Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents
- (2019) Alessandro Rossi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma
- (2019) Inna Smalley et al. EBioMedicine
- Acquisition of resistance to vemurafenib leads to interleukin-10 production through an aberrant activation of Akt in a melanoma cell line
- (2018) Takashi Inozume et al. JOURNAL OF DERMATOLOGY
- GOnet: a tool for interactive Gene Ontology analysis
- (2018) Mikhail Pomaznoy et al. BMC BIOINFORMATICS
- Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression
- (2018) Shuang Zhao et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness
- (2018) Stefania Rossi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Bortezomib sensitizes thyroid cancer to BRAF inhibitor in vitro and in vivo
- (2017) Koji Tsumagari et al. ENDOCRINE-RELATED CANCER
- Proteasome Structure and Assembly
- (2017) Lauren Budenholzer et al. JOURNAL OF MOLECULAR BIOLOGY
- ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells
- (2017) Giulia Cesi et al. Molecular Cancer
- Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance
- (2017) Bhargavi Pulluri et al. PHARMACOLOGICAL RESEARCH
- CD147 expression was positively linked to aggressiveness and worse prognosis of gastric cancer: a meta and bioinformatics analysis
- (2017) Hua-Chuan Zheng et al. Oncotarget
- Repressing CD147 is a novel therapeutic strategy for malignant melanoma
- (2017) Xing Hu et al. Oncotarget
- Update on the optimal use of bortezomib in the treatment of multiple myeloma
- (2017) Meera Mohan et al. Cancer Management and Research
- Cytokines in cancer drug resistance: Cues to new therapeutic strategies
- (2016) Valerie Sloane Jones et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Tumor-derived factors modulating dendritic cell function
- (2016) Jinbao Zong et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor
- (2016) Simona Caporali et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible
- (2016) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation
- (2016) Silvana Sandri et al. PHARMACOLOGICAL RESEARCH
- Targeting the CCL2-CCR2 signaling axis in cancer metastasis
- (2016) Su Yin Lim et al. Oncotarget
- BRAF inhibitors: the current and the future
- (2015) Weijiang Zhang CURRENT OPINION IN PHARMACOLOGY
- Melanoma-derived factors alter the maturation and activation of differentiated tissue-resident dendritic cells
- (2015) Kristian M Hargadon et al. IMMUNOLOGY AND CELL BIOLOGY
- Modulatory effects of bortezomib on host immune cell functions
- (2015) Samuel Troy Pellom et al. Immunotherapy
- Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis
- (2015) Jo Marie Tran Janco et al. JOURNAL OF IMMUNOLOGY
- Therapy-induced tumour secretomes promote resistance and tumour progression
- (2015) Anna C. Obenauf et al. NATURE
- Immunogenic, cellular, and angiogenic drivers of tumor dormancy-a melanoma view
- (2015) Daniela Senft et al. Pigment Cell & Melanoma Research
- Overcoming Resistance to Targeted Therapies in Cancer
- (2015) Keara L. Redmond et al. SEMINARS IN ONCOLOGY
- Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
- (2015) Elisabetta Vergani et al. Oncotarget
- Mitochondrial oxidative stress is the achille’s heel of melanoma cells resistant to Braf-mutant inhibitor
- (2015) Paola Corazao-Rozas et al. Oncotarget
- Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma
- (2015) Aparna Jayachandran et al. Oncotarget
- CD147 Interacts with NDUFS6 in Regulating Mitochondrial Complex I Activity and the Mitochondrial Apoptotic Pathway in Human Malignant Melanoma Cells
- (2014) Z. Luo et al. CURRENT MOLECULAR MEDICINE
- The immune escape in melanoma: role of the impaired dendritic cell function
- (2014) Marco Tucci et al. Expert Review of Clinical Immunology
- Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptor
- (2014) Matthew R. Zeiderman et al. JOURNAL OF SURGICAL RESEARCH
- Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma
- (2014) Jiao Wu et al. Journal of Translational Medicine
- Fisetin Inhibits Human Melanoma Cell Invasion through Promotion of Mesenchymal to Epithelial Transition and by Targeting MAPK and NFκB Signaling Pathways
- (2014) Harish Chandra Pal et al. PLoS One
- Neuropilin-2 gene expression correlates with malignant progression in cutaneous melanoma
- (2013) M. Rossi et al. BRITISH JOURNAL OF DERMATOLOGY
- Dormant Mycobacterium tuberculosis Fails To Block Phagosome Maturation and Shows Unexpected Capacity To Stimulate Specific Human T Lymphocytes
- (2013) S. Mariotti et al. JOURNAL OF IMMUNOLOGY
- Functional Classification of Cellular Proteome Profiles Support the Identification of Drug Resistance Signatures in Melanoma Cells
- (2013) Verena Paulitschke et al. JOURNAL OF PROTEOME RESEARCH
- BRAF V600E Is a Determinant of Sensitivity to Proteasome Inhibitors
- (2013) D. Zecchin et al. MOLECULAR CANCER THERAPEUTICS
- Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins
- (2013) Vincenzo Verdoliva et al. PLoS One
- AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma
- (2013) W Hu et al. Cell Death & Disease
- Advances in the proteomic investigation of the cell secretome
- (2012) Kristy J Brown et al. Expert Review of Proteomics
- Interleukin-6 and melanoma
- (2012) Lise Hoejberg et al. MELANOMA RESEARCH
- IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence
- (2011) Eijun Itakura et al. MODERN PATHOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD147/basigin promotes progression of malignant melanoma and other cancers
- (2010) Takuro Kanekura et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β
- (2009) Miyako Okamoto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Extracellular, circulating proteasomes and ubiquitin — Incidence and relevance
- (2008) Stephan U. Sixt et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration
- (2008) Maria Carla Bosco et al. IMMUNOBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now